Remdesivir API 1809249-37-3 Remdesivir (GS-5734)
Description:
API name: Remdesivir API
Certificates: GMP, DMF
CAS No.: 1809249-37-3
Chemical name:
L-Alanine,N-[(S)-hydroxyphenoxyphosphinyl]-,2-ethylbutylester,6-esterwith2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile;Remdesivir;RemdesivirAPI;Remdesivir(GS-5734);GS5Chemicalbook734;2-ethylbutyl(2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate;RemdesivirPowder;highpurityRemdesivir
Formula: C27H35N6O8P
Structure:
Usage:
Intravenous remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in adults and pediatric patients aged ≥28 days and weighing ≥3 kg.
Specification Sheet (In-house specification):
Item |
Specification |
Appearance |
White or off-white powder |
Identification |
IR: corresponding to the reference |
HPLC: corresponding to the reference |
|
Clarity and color of solution |
Should conform the requirement |
Water |
≤5.0% |
Loss on drying |
≤0.5% |
PH |
4.0~10.0 |
Heavy metals |
≤20ppm |
Related substances |
Any unknown impurity ≤0.1% |
Total impurities ≤1.0% |
|
Residual solvent |
Ethanol≤5000ppm |
Methanol≤3000ppm |
|
Microbial limit |
Total aerobic bacterial count ≤100CFU/g |
Total mold and yeast≤100CFU/g |
|
Assay |
98.0%~102.0% |
HS Code:N/A
JL Pharm is profesional producer and supplier for Remdesivir, we can supply DMF, Local GMP for this product, capacity is 1000kg/year. If you want to order produce Remdesivir, please let us know.
Description:
API name: Remdesivir API
Certificates: GMP, DMF
CAS No.: 1809249-37-3
Chemical name:
L-Alanine,N-[(S)-hydroxyphenoxyphosphinyl]-,2-ethylbutylester,6-esterwith2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile;Remdesivir;RemdesivirAPI;Remdesivir(GS-5734);GS5Chemicalbook734;2-ethylbutyl(2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate;RemdesivirPowder;highpurityRemdesivir
Formula: C27H35N6O8P
Structure:
Usage:
Intravenous remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in adults and pediatric patients aged ≥28 days and weighing ≥3 kg.
Specification Sheet (In-house specification):
Item |
Specification |
Appearance |
White or off-white powder |
Identification |
IR: corresponding to the reference |
HPLC: corresponding to the reference |
|
Clarity and color of solution |
Should conform the requirement |
Water |
≤5.0% |
Loss on drying |
≤0.5% |
PH |
4.0~10.0 |
Heavy metals |
≤20ppm |
Related substances |
Any unknown impurity ≤0.1% |
Total impurities ≤1.0% |
|
Residual solvent |
Ethanol≤5000ppm |
Methanol≤3000ppm |
|
Microbial limit |
Total aerobic bacterial count ≤100CFU/g |
Total mold and yeast≤100CFU/g |
|
Assay |
98.0%~102.0% |
HS Code:N/A
JL Pharm is profesional producer and supplier for Remdesivir, we can supply DMF, Local GMP for this product, capacity is 1000kg/year. If you want to order produce Remdesivir, please let us know.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View